Group 1 - The legal opinion letter confirms that the 2025 second extraordinary general meeting of Shandong WoHua Pharmaceutical Technology Co., Ltd. was convened and held in accordance with the relevant laws and regulations [1][7] - The meeting was announced with details regarding the time, location, voting methods, and agenda, and the actual meeting adhered to the announced details [2][3] - The meeting had a total of 300,498,898 shares with voting rights present, accounting for 52.0606% of the total shares [2][3] Group 2 - The meeting utilized both on-site and online voting methods, with 353 shareholders participating in online voting, holding 3,086,619 shares, which is 0.5347% of the total shares [3][4] - The voting results showed that all resolutions were passed, with specific percentages of approval from both general and minority shareholders [4][5][6] - The legal opinion concludes that the meeting's procedures, participant qualifications, and voting results are all valid and comply with the relevant laws and regulations [7]
沃华医药: 关于沃华医药2025年第二次临时股东会的法律意见书